264 related articles for article (PubMed ID: 22398730)
1. Neuroinflammation and common mechanism in Alzheimer's disease and prion amyloidosis: amyloid-associated proteins, neuroinflammation and neurofibrillary degeneration.
Rozemuller AJ; Jansen C; Carrano A; van Haastert ES; Hondius D; van der Vies SM; Hoozemans JJ
Neurodegener Dis; 2012; 10(1-4):301-4. PubMed ID: 22398730
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical localization of 14.3.3 zeta protein in amyloid plaques in human spongiform encephalopathies.
Richard M; Biacabe AG; Streichenberger N; Ironside JW; Mohr M; Kopp N; Perret-Liaudet A
Acta Neuropathol; 2003 Mar; 105(3):296-302. PubMed ID: 12557018
[TBL] [Abstract][Full Text] [Related]
3. Selective PrP-like protein, doppel immunoreactivity in dystrophic neurites of senile plaques in Alzheimer's disease.
Ferrer I; Freixas M; Blanco R; Carmona M; Puig B
Neuropathol Appl Neurobiol; 2004 Aug; 30(4):329-37. PubMed ID: 15305978
[TBL] [Abstract][Full Text] [Related]
4. Cerebral amyloid angiopathy with co-localization of prion protein and beta-amyloid in an 85-year-old patient with sporadic Creutzfeldt-Jakob disease.
Paquet C; Privat N; Kaci R; Polivka M; Dupont O; Haïk S; Laplanche JL; Hauw JJ; Gray F
Acta Neuropathol; 2008 Nov; 116(5):567-73. PubMed ID: 18551298
[TBL] [Abstract][Full Text] [Related]
5. Cerebrovascular P-glycoprotein expression is decreased in Creutzfeldt-Jakob disease.
Vogelgesang S; Glatzel M; Walker LC; Kroemer HK; Aguzzi A; Warzok RW
Acta Neuropathol; 2006 May; 111(5):436-43. PubMed ID: 16523342
[TBL] [Abstract][Full Text] [Related]
6. Increased tau accumulation in senile plaques as a hallmark in Alzheimer's disease.
Shin RW; Ogomori K; Kitamoto T; Tateishi J
Am J Pathol; 1989 Jun; 134(6):1365-71. PubMed ID: 2502927
[TBL] [Abstract][Full Text] [Related]
7. The spatial patterns of prion protein deposits in Creutzfeldt-Jakob disease: comparison with beta-amyloid deposits in Alzheimer's disease.
Armstrong RA; Lantos PL; Cairns NJ
Neurosci Lett; 2001 Jan; 298(1):53-6. PubMed ID: 11154834
[TBL] [Abstract][Full Text] [Related]
8. Toluidine blue-O staining of prion protein deposits.
Sánchez A; Guzmán A; Ortiz A; Rembao D; Espinosa B; Zenteno E; Guevara J
Histochem Cell Biol; 2001 Dec; 116(6):519-24. PubMed ID: 11810193
[TBL] [Abstract][Full Text] [Related]
9. Immunolocalization of heparan sulfate proteoglycans to the prion protein amyloid plaques of Gerstmann-Straussler syndrome, Creutzfeldt-Jakob disease and scrapie.
Snow AD; Wight TN; Nochlin D; Koike Y; Kimata K; DeArmond SJ; Prusiner SB
Lab Invest; 1990 Nov; 63(5):601-11. PubMed ID: 1977959
[TBL] [Abstract][Full Text] [Related]
10. The epsilon isoform of 14-3-3 protein is a component of the prion protein amyloid deposits of Gerstmann-Sträussler-Scheinker disease.
Di Fede G; Giaccone G; Limido L; Mangieri M; Suardi S; Puoti G; Morbin M; Mazzoleni G; Ghetti B; Tagliavini F
J Neuropathol Exp Neurol; 2007 Feb; 66(2):124-30. PubMed ID: 17278997
[TBL] [Abstract][Full Text] [Related]
11. Hyperphosphorylated tau deposition parallels prion protein burden in a case of Gerstmann-Sträussler-Scheinker syndrome P102L mutation complicated with dementia.
Ishizawa K; Komori T; Shimazu T; Yamamoto T; Kitamoto T; Shimazu K; Hirose T
Acta Neuropathol; 2002 Oct; 104(4):342-50. PubMed ID: 12200619
[TBL] [Abstract][Full Text] [Related]
12. Extracellular protein deposition correlates with glial activation and oxidative stress in Creutzfeldt-Jakob and Alzheimer's disease.
Van Everbroeck B; Dobbeleir I; De Waele M; De Leenheir E; Lübke U; Martin JJ; Cras P
Acta Neuropathol; 2004 Sep; 108(3):194-200. PubMed ID: 15221335
[TBL] [Abstract][Full Text] [Related]
13. Ultrastructural study of florid plaques in variant Creutzfeldt-Jakob disease: a comparison with amyloid plaques in kuru, sporadic Creutzfeldt-Jakob disease and Gerstmann-Sträussler-Scheinker disease.
Sikorska B; Liberski PP; Sobów T; Budka H; Ironside JW
Neuropathol Appl Neurobiol; 2009 Feb; 35(1):46-59. PubMed ID: 18513219
[TBL] [Abstract][Full Text] [Related]
14. [Alzheimer's disease: lesions and their progression].
Duyckaerts C; Colle MA; Delatour B; Hauw JJ
Rev Neurol (Paris); 1999; 155 Suppl 4():S17-27. PubMed ID: 10637934
[TBL] [Abstract][Full Text] [Related]
15. Creutzfeldt-Jakob disease patients with congophilic kuru plaques have the missense variant prion protein common to Gerstmann-Sträussler syndrome.
Doh-ura K; Tateishi J; Kitamoto T; Sasaki H; Sakaki Y
Ann Neurol; 1990 Feb; 27(2):121-6. PubMed ID: 2180366
[TBL] [Abstract][Full Text] [Related]
16. Association between deposition of beta-amyloid and pathological prion protein in sporadic Creutzfeldt-Jakob disease.
Debatin L; Streffer J; Geissen M; Matschke J; Aguzzi A; Glatzel M
Neurodegener Dis; 2008; 5(6):347-54. PubMed ID: 18349519
[TBL] [Abstract][Full Text] [Related]
17. Enhanced expression of 14-3-3 proteins in reactive astrocytes in Creutzfeldt-Jakob disease brains.
Kawamoto Y; Akiguchi I; Jarius C; Budka H
Acta Neuropathol; 2004 Oct; 108(4):302-8. PubMed ID: 15235801
[TBL] [Abstract][Full Text] [Related]
18. Olfactory tau pathology in Alzheimer disease and mild cognitive impairment.
Attems J; Jellinger KA
Clin Neuropathol; 2006; 25(6):265-71. PubMed ID: 17140156
[TBL] [Abstract][Full Text] [Related]
19. [Treatment strategy of Alzheimer's disease: pause in clinical trials of Abeta vaccine and next steps].
Kuzuhara S
Brain Nerve; 2010 Jul; 62(7):659-66. PubMed ID: 20675870
[TBL] [Abstract][Full Text] [Related]
20. Redox metals and oxidative abnormalities in human prion diseases.
Petersen RB; Siedlak SL; Lee HG; Kim YS; Nunomura A; Tagliavini F; Ghetti B; Cras P; Moreira PI; Castellani RJ; Guentchev M; Budka H; Ironside JW; Gambetti P; Smith MA; Perry G
Acta Neuropathol; 2005 Sep; 110(3):232-8. PubMed ID: 16096758
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]